Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

515 ARTÍCULOS , VIENDO DEL 346 AL 360

Longitudinal Phospho-tau217 Predicts Amyloid Positron Emission Tomography in Asymptomatic Alzheimer's Disease

Rissman RA, Donohue MC, Langford O, Raman R, Abdel-Latif S, Yaari R, Holdridge KC, Sims JR, Molina-Henry D, Jimenez-Maggiora G, Johnson KA, Aisen PS, Sperling RA.

J Prev Alzheimers Dis. 2024;11(4):823-830. doi: 10.14283/jpad.2024.134.

Novel Blood-Based Biomarkers and Disease Modifying Therapies for Alzheimer's Disease. Are We Ready for the New Era?

Korologou-Linden R, Kalsi J, Kafetsouli D, Olawale A, Iwata A, Wingfield D, Mummery D, Hayhoe B, Robinson O, Majeed A, Middleton LT.

J Prev Alzheimers Dis. 2024;11(4):897-902. doi: 10.14283/jpad.2024.83.

Alzheimer's disease: from early pathogenesis to novel therapeutic approaches

Prajapati SK, Pathak A, Samaiya PK.

Metab Brain Dis. 2024 Aug;39(6):1231-1254. doi: 10.1007/s11011-024-01389-6. Epub 2024 Jul 24.

Research progress on humoral biomarkers of Alzheimer's disease: A review

Zhang H, Fu X, Yang M, Song X, Li M, Wang X.

Medicine (Baltimore). 2024 Jul 26;103(30):e38978. doi: 10.1097/MD.0000000000038978.

Nucleic Acids-Based Biomarkers for Alzheimer's Disease Diagnosis and Novel Molecules to Treat the Disease

Bivona G, Sammataro S, Ghersi G.

Int J Mol Sci. 2024 Jul 19;25(14):7893. doi: 10.3390/ijms25147893.

Are Blood Tests for Alzheimer Disease Ready for Prime Time?

Salloway S, Rowe C, Burns JM.

JAMA. 2024 Oct 15;332(15):1240-1241. doi: 10.1001/jama.2024.12814.

Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care

Palmqvist S, Tideman P, Mattsson-Carlgren N, Schindler SE, Smith R, Ossenkoppele R, Calling S, West T, Monane M, Verghese PB, Braunstein JB, Blennow K, Janelidze S, Stomrud E, Salvadó G, Hansson O.

JAMA. 2024 Oct 15;332(15):1245-1257. doi: 10.1001/jama.2024.13855.

γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS)

Schultz SA, Liu L, Schultz AP, Fitzpatrick CD, Levin R, Bellier JP, Shirzadi Z, Joseph-Mathurin N, Chen CD, Benzinger TLS, Day GS, Farlow MR, Gordon BA, Hassenstab JJ, Jack CR Jr, Jucker M, Karch CM, Lee JH, Levin J, Perrin RJ, Schofield PR, Xiong C, Johnson KA, McDade E, Bateman RJ, Sperling RA, Selkoe DJ, Chhatwal JP; Dominantly Inherited Alzheimer Network.

Lancet Neurol. 2024 Sep;23(9):913-924. doi: 10.1016/S1474-4422(24)00236-9. Epub 2024 Jul 26.

Clinical significance of plasma candidate biomarkers of Alzheimer's Disease

Lewczuk P, Łukaszewicz-Zając M, Kornhuber J, Mroczko B.

Neurol Neurochir Pol. 2024;58(4):363-379. doi: 10.5603/pjnns.100675. Epub 2024 Aug 2.

Transcranial blood-brain barrier opening in Alzheimer's disease patients using a portable focused ultrasound system with real-time 2-D cavitation mapping

Bae S, Liu K, Pouliopoulos AN, Ji R, Jiménez-Gambín S, Yousefian O, Kline-Schoder AR, Batts AJ, Tsitsos FN, Kokossis D, Mintz A, Honig LS, Konofagou EE.

Theranostics. 2024 Jul 22;14(11):4519-4535. doi: 10.7150/thno.94206. eCollection 2024.

Design and validation of the ADNI MR protocol

Arani A, Borowski B, Felmlee J, Reid RI, Thomas DL, Gunter JL, Stables L, Buckner RL, Jung Y, Tosun D, Weiner M, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2024 Sep;20(9):6615-6621. doi: 10.1002/alz.14162. Epub 2024 Aug 8.

Psychosocial implications of learning amyloid PET results in an observational cohort

Clark LR, Erickson CM, Chin NA, Basche KE, Ketchum FB, Rosario HL, Peterson AJ, Eveler ML, Johnson SC.

Alzheimers Dement. 2024 Sep;20(9):6579-6589. doi: 10.1002/alz.14153. Epub 2024 Aug 11.

The informatics of ADNI

Toga AW, Neu S, Sheehan ST, Crawford K; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2024 Oct;20(10):7320-7330. doi: 10.1002/alz.14099. Epub 2024 Aug 14.

Contributions of the ADNI Biostatistics Core

Beckett LA, Saito N, Donohue MC, Harvey DJ; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2024 Oct;20(10):7331-7339. doi: 10.1002/alz.14159. Epub 2024 Aug 14.

Towards discovery and implementation of neurophysiologic biomarkers of Alzheimer's disease using entropy methods

Simmatis LER, Russo EE, Altug Y, Murugathas V, Janevski J, Oh D, Chiu Q, Harmsen IE, Samuel N.

Neuroscience. 2024 Oct 18;558:105-113. doi: 10.1016/j.neuroscience.2024.08.017. Epub 2024 Aug 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias